Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

FN

Fabrinet (FN) Smashes Revenue Records

Fabrinet (NYSE: FN) has reported its financial results for the second fiscal quarter ended December 26, 2025, delivering record-breaking figures that exceeded the guidance ranges.

In terms of GAAP results, revenue for the second quarter of fiscal year 2026 was $1,132.9 million, a substantial increase from $833.6 million for the same period in fiscal year 2025. GAAP net income for the second quarter of fiscal year 2026 was $112.6 million, compared to $86.6 million for the second quarter of fiscal year 2025. GAAP net income per diluted share for the second quarter of fiscal year 2026 was $3.11, up from $2.38 for the second quarter of fiscal year 2025.

Looking at the non-GAAP results, the second quarter of fiscal year 2026 saw non-GAAP net income of $121.6 million, a notable jump from $95.1 million for the second quarter of fiscal year 2025. Non-GAAP net income per diluted share for the second quarter of fiscal year 2026 was $3.36, compared to $2.61 for the second quarter of fiscal year 2025.

Fabrinet also provided an outlook for its third fiscal quarter ending March 27, 2026. The company expects third quarter revenue to be in the range of $1.15 billion to $1.20 billion. They anticipate GAAP net income per diluted share to be in the range of $3.22 to $3.37, and non-GAAP net income per diluted share to be in the range of $3.45 to $3.60.

These results reflect the company's exceptional performance and strong growth trajectory, positioning them for continued success in the coming quarters. The market has reacted to these announcements by moving the company's shares -0.63% to a price of $494.45. For the full picture, make sure to review Fabrinet's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS